sing oxygen to improve exercise performance in patients with cystic fibrosis

Not Applicable

Completed

• Conditions: Cystic fibrosis; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN13864650
• Lead Sponsor: School of Health and Human Performance, Dublin City University

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32308986/ (added 23/10/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2010-07-04
• Study Start: 2019-07-16
• Last Update Posted: 2 November 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

1. Diagnosis of CF that was based on clinical features, sweat test, or genotyping, and a pulmonary function test
2. Age > 18 years
3. Forced expiratory in one second (FEV1) > 30% predicted
4. Clinically stable

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maximal exercise capacity measured using an incremental symptom-limited peak exercise test on an electronically-braked cycle ergometer while breathing through a full face mask measured at baseline and 12-weeks.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Anthropometric measurements: height and body mass were measured and double thickness subcutaneous adipose tissue was determined on the right side of the body using skinfold calipers, at the first visit.<br> 2. Pulmonary function tests: spirometry and single-breath carbon monoxide diffusion capacity were measured at the first visit.<br>